About

Call for Papers: DNA and RNA Cardiovascular Therapeutics

July 7, 2021

JACC: Basic to Translational Science is planning a uniquely themed issue highlighting therapies that use DNA and RNA therapeutics to target cardiovascular disease. The journal is accepting submissions spanning the theme, including those applying therapeutic strategies such as gene therapy, CRISPR–Cas9 gene editing, mRNAs, microRNAs, small interfering RNAs, long noncoding RNAs, antisense oligonucleotides, aptamers, nanotherapeutics, development of targeted adenoviral vectors, and catheter delivery systems for cardiovascular applications. Submissions are due Dec. 1 of this year, with final publication planned for the September 2022 issue. Learn more and submit.
 

Print